Delarasse, Cécile

Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1

Vacchelli, E., Ma, Y., Baracco, E. E., Sistigu, A., Enot, D. P., Pietrocola, F., Yang, H., Adjemian, S., Chaba, K., Semeraro, M., et al. (2015) · Science

Immunotherapy and Immune ResponsesChemokine receptors and signaling

Cited by 452

New role of P2X7 receptor in an Alzheimer’s disease mouse model

Martin, E., Amar, M., Dalle, C., Youssef, I., Boucher, C., Le Duigou, C., Brückner, M., Prigent, A., Sazdovitch, V., Halle, A., et al. (2019) · Molecular Psychiatry

Adenosine and Purinergic SignalingAlzheimer's disease research and treatments

Cited by 187

Distinct inflammatory phenotypes of microglia and monocyte‐derived macrophages in Alzheimer's disease models: effects of aging and amyloid pathology

Martin, E., Boucher, C., Fontaine, B., & Delarasse, C. (2017) · Aging Cell

Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments

Cited by 156

The 10q26 Risk Haplotype of Age-Related Macular Degeneration Aggravates Subretinal Inflammation by Impairing Monocyte Elimination

Beguier, F., Housset, M., Roubeix, C., Augustin, S., Zagar, Y., Nous, C., Mathis, T., Eandi, C., Benchaboune, M., Drame-Maigné, A., et al. (2020) · Immunity

Retinal Diseases and TreatmentsPhagocytosis and Immune Regulation

Cited by 87

Pleiotropic Roles of P2X7 in the Central Nervous System

Kanellopoulos, J. M., & Delarasse, C. (2019) · Frontiers in Cellular Neuroscience

Adenosine and Purinergic SignalingPain Mechanisms and Treatments

Cited by 48

Ezrin/Radixin/Moesin Are Required for the Purinergic P2X7 Receptor (P2X7R)-dependent Processing of the Amyloid Precursor Protein

Darmellah, A., Rayah, A., Auger, R., Cuif, M.-H., Prigent, M., Arpin, M., Alcover, A., Delarasse, C., & Kanellopoulos, J. M. (2012) · Journal of Biological Chemistry

Alzheimer's disease research and treatmentsAdenosine and Purinergic Signaling

Cited by 38